Mumbai, India , is rapidly emerging as a significant hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several organizations have established substantial manufacturing plants focusing on this critical antiviral compound. Identifying the precise top manufacturers can be complex due to fluctuating market dynamics, but reputable names